4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics

Retrieved on: 2021-04-20 12:56:15

Tags for this article:

Click the tags to see associated articles and topics

4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics. View article details on hiswai:

Excerpt

... UPMC Enterprises, with participation from CureDuchenne Ventures, The JDRF T1D Fund, New Enterprise Associates, and Takeda Ventures, Inc.

Article found on: www.globenewswire.com